Skip menus, go to main page content

To Our Shareholders
and Investors

Top
To Our Shareholders and Investors

IR News

August 06, 2026

Management & Finance

Outline of Consolidated Financial Results for the First Quarter Ended June 30, 2026
July 30, 2026

R & D

Nippon Shinyaku Exercises Option Rights for Commercialization of AB2 Bio’s Tadekinig alfa in the U.S.
July 22, 2026

R & D

Nippon Shinyaku Enters into an Exclusive License Agreement for the Development, Manufacturing, and Commercialization of NS-025 Worldwide
July 21, 2026

Management & Finance

Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation

Upcoming Events

August 06, 2026
FY2026 1st Qtr results announcement and IR meeting
May 15, 2026
Annual results announcement and IR meeting （Q4/FY2025）
March 02, 2026
R&D Meeting
February 09, 2026
IR Meeting (Q3/FY2025)
February 09, 2026
FY2025 3rd Qtr Results Announcement

Financial/Capital Strategy

Management Policy and Plan

Business/Financial Information

IR Library

Sustainability Management

Stock and Shareholder Information

To Our Individual Investors

IR e-mail

Subscribe (only 1 minute required) to receive the latest news by e-mail.

Most Viewed Pages

Jul 1-31, 2026

All Japanese Listed Companies' Website Ranking

Gomez
IR Site Ranking Silver 2025

Daiwa Investor Relations Co.Ltd. 2025 Internet IR Award

Related Link

Nippon Shinyaku’s DNA

Research & Development

Top
To Our Shareholders and Investors